Recurrent acute myeloid leukemia, myelodysplasia-related

Clinical trials for Recurrent acute myeloid leukemia, myelodysplasia-related explained in plain language.

Never miss a new study

Get alerted when new Recurrent acute myeloid leukemia, myelodysplasia-related trials appear

Sign up with your email to follow new studies for Recurrent acute myeloid leukemia, myelodysplasia-related, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Experimental combo aims to outsmart relapsed blood cancers

Disease control Ongoing

This early-stage trial tests whether adding the immunotherapy drug ipilimumab to the chemotherapy drug decitabine is safe and tolerable for people with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) that has come back or stopped responding to treatment. About 54 p…

Matched conditions: RECURRENT ACUTE MYELOID LEUKEMIA, MYELODYSPLASIA-RELATED

Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Sep 11, 2026 00:00 UTC

Recurrent acute myeloid leukemia, myelodysplasia-related

Get alerted when new Recurrent acute myeloid leukemia, myelodysplasia-related trials appear

Experimental combo aims to outsmart relapsed blood cancers